Mass spectrometry of the proteome

Molecular Pharmacology

Volumn 60, Issue 3, 2001, Pages 405-415

  Bakhtiar, Ray ^a,c   Nelson, Randall W ^b,d  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b Intrinsic Bioprobes Incorporated   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Intrinsic Bioprobes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ACCURACY; ANALYTIC METHOD; AUTOMATION; DIAGNOSTIC VALUE; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MODIFICATION; SENSITIVITY AND SPECIFICITY; SHORT SURVEY;

ANIMALS; BIOLOGICAL MARKERS; FORECASTING; HUMANS; PROTEOME; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0034872084     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (94)

1. Mass spectrometry in proteomics
2. Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry
3. Back to the future: The human protein index (HPI) and the agenda for post-proteomic biology
4. Biological mass spectrometry: A primer
5. Electrospray ionization and matrix-assisted laser desorption ionization mass spectrometry
6. Matrix-assisted laser desorption/ionization coupled with quadrupole/orthogonal acceleration time-of-flight mass spectrometry for protein discovery, identification, and structural analysis
7. Conformational analysis of cyclic hexapeptides designed as constrained ligands for the SH2 domain of the p85 subunit of phosphatidylinositel-2-OH kinase
8. Cancer proteomics From biomarker discovery to signal pathway profiling
9. Toward a clinical molecular scanner for proteome research: Parallel protein chemical processing before and during Western blot
10. Monitoring enzyme catalysis with mass spectrometry
11. Sequencing the entire genomes of free-living organisms: The foundation of pharmacalogy in the new millennium
12. High-throughput development and characterization of a genome wide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
13. Mass spectrometry in the clinical laboratory
14. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis
15. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching
16. Automated LC-LC-MS.MS platform using binary ion-exchange and gradient reversed-phase chromatography for improved proteomic analyses
17. Glycoprotein structure determination by mass spectrometry
18. Determination of protein-protein interactions by matrix-assisted laser desorption/ionization mass spectrometry
19. Identifying the proteome: Software tools
20. Electrochemical processes in electrospray ionization mass spectrometry
21. Proteomics on a chip: Promising developments
22. Integrating molecular medicine with functional proteomics: Realities and expectations
23. Perspectives for mass spectrometry and functional proteomics
24. Integrating expression-based drug response and SNP-based pharmacogenetic strategies into a single comprehensive pharmacogenomics program
25. Direct genetic analysis by matrix-assisted laser desorption/ionization mass spectrometry
26. Quantitative proteomic analysis using a MALDI quadrupole time-of-flight mass spectrometer
27. Identification of β-secretase-like activity using a mass spectrometry-based assay system
28. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
29. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology
30. Measuring gene expression by quantitative proteome analysis
31. Mass spectrometry and proteomics
32. Characterization of enzymatic processes by rapid mix-quench mass spectrometry: The case of dTDP-glucose 4,6-dehyratase
33. Integrated genomic/proteomic analysis
34. Proteomic profiling-pitfalls and progress
35. Analysis of noncovalent complexes of DNA and RNA by mass spectrometry
36. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes
37. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network
38. Peptide sequencing of 2-DE gel-isolated proteins by nanoelectrospray tandem mass spectrometry
39. Strategy for qualitative and quantitative analysis in proteomics based on signature peptides
40. Proteomics meets cell biology: The establishment of subcellular proteomes
41. Protein microarrays: Prospects and problems
42. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites
43. Idiosyncratic drug reactions: The reactive metabolite syndromes
44. Mass spectrometric immunoassay
45. High-throughput high-performance liquid-chromatography/mass spectrometry for modern drug discovery
46. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry
47. Mass spectrometry: A tool for the identification of proteins separated by gels
48. Initial sequencing and analysis of the human genome
49. Incident of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
50. Direct analysis of protein complexes using mass spectrometry
51. High-throughput profiling of the mitochondrial proteome using fractionation and automation
52. Use of mass spectrometry-derived data to annotate nucleotide and protein sequence databases
53. Pharmacogenomics: The genomics of drug response
54. Site-specific phosphorylation of human p53 protein determined by mass spectrometry
55. Pharmacogenomics: Unlocking the human genome for better drug therapy
56. Imaging and detection technologies for image analysis in electrophoresis
57. Application of time-of-flight mass spectroscopy for the quantitative analysis of biological molecules
58. Quantitative and facilitated de Novo sequencing of proteins by isotope N-terminal labeling of peptides with a fragmentation-directing moiety
59. Quantitative-determination of proteins by matrix-assisted laser-desorption ionization time-of-flight mass-spectrometry
60. Mass-spectrometric immunoassay
61. BIA/MS of epitope-tagged peptides directly from E. coli lysate: Multiplex detection and protein identification at low-femtomole to subfemtomole levels
62. Advances in surface plasmon resonance biomolecular interaction analysis mass spectrometry (BIA/MS)
63. Biosensor chip mass spectrometry: A chip-based proteomics approach
64. Characterization of the glycosylation sites in cyclooxygenase-2 using mass spectrometry
65. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex
66. Mapping phosphorylation sites of gel-isolated proteins by nanoelectrospray tandem mass spectrometry: Potentials and limitations
67. Mass spectrometry in the search for uremic toxins
68. Analysis of enzyme kinetics using electrospray ionization mass spectrometry and multiple reaction monitoring: Fucosyltransferase V
69. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome
70. Proteomics to study genes and genomes
71. Analysis of receptor signaling pathways by mass spectrometry: Identification of Vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors
72. High throughput proteome-wide precision measurements of protein expression using mass spectrometry
73. Immobilized gallium(III) affinity chromatography of phosphopeptides
74. Direct analysis of the products of sequential cleavages of peptides and proteins affinity-bound to immobilized metal ion beads by matrix- assisted laser desorption/ionization mass spectrometry
75. Detecting proteins separated by 2-D gel electrophoresis
76. Affinity mass spectrometry-based approaches for the analysis of protein-protein interaction and complex mixtures of peptide-ligands
77. Simplification of complex peptide mixtures for proteomic analysis: Reversible biotinylation of cysteinyl peptides
78. Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode
79. Rapid genotyping by MALDI-monitored nuclease selection from probe libraries
80. Mass spectrometry in viral proteomics
81. Separations combined with mass spectrometry
82. Detection and quantification of β-2-microglobulin using mass spectrometric immunoassay (MSIA)
83. Mass spectrometric resolution of reversible protein phosphorylation in photosynthetic membranes of Arabidopsis thaliana
84. The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry
85. Large-scale analysis of the yeast proteome by multidimensional protein identification technology
86. Proteomics - The protein expression technology to study connective tissue biology
87. Genomes and proteomes: Toward a multidimensional view of biology
88. Parent ion scans of unseparated peptide mixtures
89. Allele-specific HLA-DR typing by mass spectrometry: An alternative to hybridization-based typing methods
90. Mass spectrometry: From genomics to proteomics
91. A systematic approach to the analysis of protein phosphorylation
92. A method for global analysis of complex proteomes using sample prefractionation by solution isoelectrophoresis prior to two-dimensional electrophoresis